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Abstract 
BACKGROUND: Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease 
worldwide. Since the effect and safety of pharmacotherapy for NAFLD are unknown, the proper management of 
lifestyle is crucial.  
AIM: The present study was conducted to determine the status of food, Physical Activity (PA), and sleep in 
patients with and without NAFLD. 
METHODS: In this analytical- cross-sectional study, 630 clients with 36-60 years old who referred to the 
PERSIAN Guilan cohort study were included through simple non-random sampling. The developed questionnaire 
and lifestyle characteristics, including the status of nutrition, physical activity, and sleep, were completed for all 
samples. BMI was also calculated by determining weight and height, and fatty liver was confirmed based on 
abdominal ultrasound. 
RESULTS: The prevalence of NAFLD in this study was by 43.7% (275 / 630). Smoking, alcohol consumption, 
BMI, and weight loss over the past six months, regular exercise and exercise intensity, sedentary living, speed of 
eating, consuming fatty food, red meat, sweets beverages, and use of saturated fatty acid (SFA), and consuming 
fruits and vegetables were associated with presence of NAFLD (all p < 0.05). However, no significant relationship 
was observed between the parameters of sleep duration, the interval between dinner and night sleep, consuming 
breakfast and snack during the day and NAFLD (All p > 0.05). 
CONCLUSION: The onset and progression of NAFLD are associated with lifestyle. Therefore, dietary therapy 
solutions, physical activity, and sleep and rest situations should be paid attention for people with or at risk of 
NAFLD. 
 
 
 
 
Introduction 
 
Non-Alcoholic Fatty Liver Disease (NAFLD) is 
the most common cause of chronic liver disease in 
worldwide, which is characterised by the accumulation 
of fat in the liver of patients with no alcohol abuse, and 
with clinical signs of simple steatosis, steatohepatitis, 
advanced fibrosis, and cirrhosis [1], [2]. Fatty liver is 
common in industrial countries, and the prevalence of 
NAFLD has been grown in the Asia-Pacific Ocean 
region over the past two decades given the Western 
lifestyle and increased incidence of obesity [3]. The 
global prevalence of NAFLD has been reported as 
around 25.24%, 31%, 32%, and 27%, respectively in 
the adult population, southern America, Middle East, 
and Asia. [4], [5] Prevalence of NAFLD in the south 
and north of Iran has been reported as 21.5% [6] and 
43.8%, [7] respectively, and it has been generally 
reported as 33.9% [8]. 
The exact NAFLD pathogenesis has 
remained unknown, though it seems to be 
multifactorial [9]. There is no consensus for the 
pharmacotherapy of NAFLD. Nevertheless, 
management of Diet and Physical Activity (PA) is an 
indispensable component of any therapeutic strategy 
for weight loss, and it may play a significant role in 
preventing NAFLD [10], [11]. Currently, the initial 
treatment involves gradual weight loss through 
reducing caloric consumption and enhancing physical 
activity to improve Liver Function Tests (LFT), Insulin 
Resistance (IR), fasting glucose levels, and lipid 
profiles. [12] Precise evaluation of extra energy 
consumption is required by the individual to obtain 
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better results in the nutritional treatment of NAFLD 
[13]. Generally, diets with high-calorie content, high 
carbohydrate, high saturated fatty acid, cholesterol, 
and soft drinks may increase the accumulation of fat 
in the liver, aggravate the clinical conditions of 
NAFLD, and cause its progression [9], [14]. On the 
other hand, restricting the calorie intake and 
increasing consumption of soy protein, Mono 
Unsaturated Fatty Acid (MUFA) supplements, omega-
3 fatty acid, and probiotics are effective in preventing 
and treating NAFLD [9]. Also, it has been believed 
that PA is one of the determinant factors for 
controlling metabolic state. NAFLD patients are 
recommended to have physical activity alongside 
losing weight and modifying diet [15], [16]. Since the 
elevation of PA has a protective role against NAFLD-
associated risk factors such as obesity, type II 
diabetes, blood pressure, and dyslipidemia, thus it 
seems that enhancing PA is effective in preventing 
NAFLD [17], [18], [19], [20]. 
Most studies have discussed various aspects 
of lifestyle such as nutrition, diet, and PA and the 
relationship with NAFLD, but other aspects such as 
sleep habits have remained understudied. Therefore, 
the present study was conducted to determine the 
relationship between lifestyle characteristics such as 
consumed food, physical activity, and sleep habits 
and NAFLD. 
 
 
Methods 
 
In this study, 630 subjects with 35-60 years 
old (from April 2017 to July 2017) among the clients 
referring to the PERSIAN Guilan cohort study (PGCS) 
part of the PERSIAN cohort study [21] were included 
in this analytical cross-sectional study through 
sequential sampling. The exclusion criteria included 
not having chronic or acute liver disease including 
viral hepatitis B and C, chronic and acute renal 
disease, cancers, and alcohol consumption (men 
above 20 g/d and women above 10 g/d), pregnancy, 
consuming medications affecting the liver such as 
steroids, amiodarone and tamoxifen, and patients with 
established hemochromatosis. Identification of the 
subjects was performed based on the PERSIAN 
cohort profile [21]. 
The information of this study was collected 
through a questionnaire which has been developed by 
the research group and as face-to-face. This 
questionnaire consisted of two sections: the first 
section captured demographic information (age, 
gender, marital status, occupation, level of education, 
and place of residence), while the second section 
involved typical lifestyle characteristics over the past 
six months.  
These characteristics included questions such 
as weight loss over the past six months, alcohol 
consumption and smoking, dietary habits (being used 
to consuming breakfast, consuming snacks during the 
day, speed of eating, type of consumed bread, 
consuming fatty food, fruits and vegetables, milk and 
dairies, sweet beverages, type of consumed oil, type 
of the main consumed meat), physical activity (regular 
exercise, exercise intensity, daily walking, type of 
activity during daily living), and sleep (duration of daily 
sleep, interval between dinner and night sleep) of the 
subjects. Trovato et al. defined lifestyle according to 
dietary habits, exercise and physical activity, and 
sleep [22]. Based on Kim et al.’s study [23], the sleep 
duration was categorised as 5 ≥, > 5-6, > 6-7, and > 7 
in this study. 
The height (cm) was measured without shoes 
(by wall stadiometer device seca206, Hamburg, 
Germany) and weight (kg) was measured with light 
clothing and without shoes (by seca755 scale, 
Hamburg, Germany) by a trained person. Body mass 
index (BMI; kg/m2) was obtained by dividing the 
weight (kg) by the height squared (m2) for all subjects. 
BMI < 25 was considered normal, while BMI ≥ 25 was 
regarded as overweight [24]. 
To determine fatty liver, in the presence and 
with confirmation of two radiologists who deployed in 
the cohort centre, abdominal ultrasound was 
performed using the ultrasonic device (sonixSP 
series) using a 3.5-5 MHz deep probe. Echogenicity 
was increased in the liver parenchyma compared to 
kidney parenchyma or spleen in abdominal ultrasound 
[25] was recorded as fatty liver. 
The data were expressed as frequency 
(percentage) and mean (standard deviation). Chi-
square test, t-test, and chance ratio were calculated 
by univariate logistic regression to compare the 
variables, where p < 0.05 was considered significant. 
All analyses were performed by SPSS 18. 
This study has been registered in the 
research and ethics committee of the Research 
Center of Gastroenterology and Hepatology and 
Guilan University of medical sciences with the number 
of IR.GUMS.REC.1394.499. Written informed consent 
form was taken from all participants to participate in 
the study. Further, they were free to quit this study at 
any stage they wished. 
 
 
Results 
 
Out of the 630 subjects, 275 (43.7%) had 
NAFLD, that 330 (52.4%) were male, whose age 
range was 35-60. The mean age was 46.99 ± 7.33 
(47.10 ± 7.10 in women and 47.76 ± 7.57 in men). 
The demographic information of the subjects is 
presented in Table 1. 
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Table 1: Demographic characteristics of participants 
NAFLD
*
 N (%) non- NAFLD N (%) Total N (%) Variables 
 
102 (41.8) 
108 (44.8) 
65 (44.8) 
 
142 (58.2) 
133 (55.2) 
80 (55.2) 
 
244 (38.7) 
241 (38.3) 
145 (23.0) 
Age (years)  
35-44 
45-54 
55-60 
 
147 (44.5) 
128(42.7) 
 
183 (55.5) 
172 (57.3) 
 
330 (52.4) 
300 (47.6) 
Gender 
Male 
Female  
 
8 (40) 
267 (43.8) 
 
12 (60) 
343 (56.2) 
 
20 (3.2) 
610 (98.8) 
Marital status 
Single  
Married  
 
27 (40.9) 
114 (45.2) 
36 (40.0) 
48 (49.5) 
50 (40) 
 
39 (59.1) 
138 (54.8) 
54 (60) 
49 (50.5) 
75 (60) 
 
66 (10.5) 
252 (40) 
90 (14.3) 
97 (15.4) 
125 (19.8) 
Job 
Farmer 
Housewife 
Employed 
Worker 
Self-employed  
 
23 (54.8) 
65 (47.1) 
156 (42.4) 
31 (37.8) 
 
19 (45.2) 
73 (52.9) 
212 (57.6) 
51 (62.2) 
 
42 (6.7) 
138 (21.9) 
368 (58.4) 
82 (13) 
Education 
Illiterate 
Elementary 
High school 
Academic 
 
195 (43) 
80 (45.5) 
 
259 (57) 
96 (54.5) 
 
454 (72.1) 
176 (27.9) 
Residence 
City 
Village 
*NAFLD non-alcoholic fatty liver disease. 
 
The results of this study indicated a significant 
relationship between smoking (p = 0.036, OR 95%CI 
= 1.47: 1.02-2.13), alcohol consumption (p = 0.030, 
OR 95%CI = 1.70: 1.05-2.75), and BMI ≥ 25 (p < 
0.001, OR 95%CI = 7.98: 4.53-14.07) between 
NAFLD and non-NAFLD group. Also, weight loss was 
significant between the groups over the past six 
months (p = 0.006, OR 95%CI = 0.59: 0.41-0.86). 
In this study, a significant relationship was 
observed between weight loss over the past six 
months as well as average BMI based on t-test and 
NAFLD (p = 0.005 and p < 0.001, respectively). 
However, there was no significant relationship 
between the duration of daily sleep (p = 0.61) and the 
interval between dinner and night sleep (p = 0.39) 
(Table 2). 
Table 2: Participants in non-NAFLD and NAFLD 
Variables non-NAFLD NAFLD P-value* 
Age (year) 47.08 ± 7.42 47.92 ± 7.23 0.15 
BMI (kg/m
2
) 26.56 ± 3.74 30.81 ± 4.47 < 0.001 
Weight loss (Last 6 months) (kg)  1.15 ± 2.47 0.68 ± 1.75 0.005 
Sleep duration(h/day) 7.22 ± 1.32 7.17 ± 1.33 0.61 
Dinner-to-night sleep interval (h) 2.65 ± 1.06 2.58 ± 0.97 0.39 
NAFLD non-alcoholic fatty liver disease; Body mass index (BMI); Data are presented as 
mean ± SD; P-value as derived by Independent sample t-test; * p < 0.05 is significant. 
 
Similarly, according to the sleep duration 
categorisation, no significant relationship was 
observed between NAFLD and non-NAFLD group 
(Table 3). 
Table 3: Comparison of sleep duration and physical activity 
between non-NAFLD and NAFLD 
OR (CI 95%) P-value* NAFLD N (%) non-NAFLD N (%) Variables 
 
1.09 (0.60-1.97) 
0.98 (0.62-1.55) 
0.72 (0.49-1.04) 
(ref) 
 
0.77 
0.95 
0.08 
- 
 
25 (48.1) 
47 (45.6) 
73 (38) 
130 (45.9) 
 
27 (51.9) 
56 (54.4) 
119 (62) 
153 (54.1) 
Sleep duration (h/day) 
≤ 5  
> 5-6 
> 6-7 
> 7  
 
0.62 (0.42-0.90) 
(ref) 
 
0.014 
 
52 (34.9) 
223 (46.4) 
 
97 (65.1) 
258 (53.6) 
Regular exercise  
Yes 
No 
 
0.15 (0.04-0.59) 
0.44 (0.22-0.89) 
(ref) 
 
0.007 
0.022 
- 
 
3 (15.8) 
30 (34.9) 
30 (54.5) 
 
16 (84.2) 
56(65.1) 
25 (45.5) 
Exercise intensity 
Intense 
Moderate 
Light 
 
0.78 (0.57-1.07) 
(ref) 
 
0.137 
 
123 (40.6) 
152 (46.5) 
 
180 (59.4) 
175 (53.5) 
Daily walking (min/day) 
 ≥ 30 min 
> 30 min  
 
1.61 (1.11-2.00) 
(ref) 
 
0.010 
 
 
81 (52.6) 
194 (40.8) 
 
73 (47.4) 
282 (59.2) 
Daily Activity 
Sedentary 
Active  
NAFLD non-alcoholic fatty liver disease; *p < 0.05 is significant. 
The results of this study indicated that the 
chance of developing NAFLD was less in those who 
had regular exercise over the past six months. (p = 
0.014, OR 95%CI = 0.62: 0.42-0.90). On the other 
hand, sedentary daily activity enhances the chance of 
developing NAFLD (p = 0.010, OR 95%CI = 1.61: 
1.11-2.00). PA comparison between the groups is 
reported in Table 2. 
In investigating the dietary habits of 
individuals with NAFLD, a significant relationship was 
observed with speed of eating (p = 0.03), consuming 
fatty food (p = 0.04), consuming fruits and vegetables 
(p = 0.03), daily consumption of sweet beverages (p = 
0.042), use of SFA (p = 0.039), and consuming red 
meat (p = 0.01) (Table 4). 
Table 4: Comparison of nutrient patterns between non-NAFLD 
and NAFLD 
OR (CI 95%) P-value* NAFLD N (%) 
non-NAFLD 
N (%) 
Variables 
 
0.42(0.13- 1.32) 
(ref) 
 
0.13 
 
 
271 (44.1) 
4 (25) 
 
343 (55.9) 
12 (75) 
Breakfast consumption 
Yes 
No 
 
0.81 (0.51- 1.28) 
(ref) 
 
0.37 
 
235 (43) 
40 (48.2) 
 
312 (57) 
43 (51.8) 
Snacks consumption  
Yes  
No  
 
1.40 (1.02-1.92) 
(ref) 
 
0.036 
 
161 (47.5) 
114 (39.2) 
 
178 (52.5) 
177 (60.8) 
Speed of eating  
Yes  
No 
 
0.97 (0.63-1.49) 
(ref) 
 
0.91 
 
230 (43.6) 
45 (44.1) 
 
298 (56.4) 
57 (55.9) 
Bread consumption  
bran-rich 
no bran 
 
1.81 (1.01-3.23) 
(ref) 
 
0.04 
 
257 (44.9) 
18 (31) 
 
315 (55.1) 
40 (69) 
Fatty food consumption 
Yes 
No 
 
2.42 (1.22- 4.81) 
1.18 (0.68- 2.05) 
(ref) 
 
0.01 
0.53 
- 
 
47 (59.5%) 
205 (41.8) 
23 (37.7%) 
 
32 (40.5%) 
285 (58.2%) 
38 (62.3%) 
Meat consumption 
Red meat 
Poultry 
Fish  
 
0.55 (0.32 -0.96) 
0.88 (0.62- 1.25) 
(ref) 
 
0.03 
0.49 
- 
 
22 (32.4) 
88 (43.1) 
165 (46.1) 
 
46 (67.6) 
116 (56.9) 
193 (53.9) 
Fruits & vegetables 
(serv./day) 3-4 
2 
< 1 
 
1.42(0.84-2.38) 
1.51 (1.01 -2.27) 
(ref) 
 
0.18 
0.04 
- 
 
48 (44.4) 
178 (46.1) 
49 (36) 
 
60 (55.6) 
208 (53.9) 
87 (64) 
Milk&dairies(glass /day) 
≥ 2  
1 
< 1 
 
1.400(1.01-1.93) 
(ref) 
 
0.042 
 
177 (46.9) 
98(38.7) 
 
200 (53.1) 
155 (61.3) 
Sweet beverages (day)  
Yes 
No 
 
1.63 (1.02-2.61) 
(ref) 
 
0.039 
 
44 (54.3) 
231 (42.1) 
 
37 (45.7) 
318 (57.9) 
Oil consumption 
SFA 
UFA 
NAFLD non-alcoholic fatty liver disease; SFA Saturated fatty acid; UFA Unsaturated fatty 
acid; *p < 0.05 is significant. 
 
 
 
Discussion 
 
The increase in the incidence of non-
communicable worldwide diseases has changed 
NAFLD into a new challenge for public health. 
Prevalence of NAFLD in the world, Eastern countries, 
and Asia has been reported as 10-30% [26], 20-30%, 
and 15-20%, respectively [27]. In Iran, the prevalence 
in the north and south of the country has been 
reported as 43.8% [6] and 15.3% [28]. In this study, 
the NAFLD prevalence was 43.7%. 
Lifestyle is an important factor for metabolic 
syndrome, and it is associated with NAFLD [29]. 
Further, exercising to lose weight is an indispensable 
Public Health 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3316                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
part of lifestyle interventions, and it is proposed as a 
useful independent item for NAFLD [22]. According to 
the results of the present study, PA is associated with 
the probability of NAFLD reduction, where individuals 
with less daily physical activity are at higher risk. 
Hallsworth, [16] Gerber [15], and Trovato [22] 
stated that those with NAFLD spend more time resting 
and have less physical activity compared to the 
control group. Long-term sitting predisposes 
individuals further to the risk of NAFLD by increasing 
the fat mass or reducing the musculoskeletal mass. 
Thus, by reducing sitting and increasing PA, one can 
decrease the risk of NAFLD [25]. 
In this study, smoking and alcohol 
consumption along with high BMI were associated 
with NAFLD, which is consistent with the results of 
previous studies on the relationship between smoking, 
[30,31] alcohol [4], [22] and BMI [1], [6], [22], [32] and 
NAFLD. The onset and progression of NAFLD, apart 
from the quantity and quality of food and exercise, are 
also associated with other aspects of lifestyle, 
including alcohol consumption less than 20 g/day [22]. 
The fat quality of the diet also seems to have 
a significant role in the progression of NAFLD. In this 
regard, consuming a diet with saturated fatty acid 
(SFA) may cause fat accumulation in the liver. In 
contrast, a diet containing Poly Unsaturated Fatty Acid 
(PUFA) has a negative effect on the extent of 
accumulation of triglyceride inside the liver [33]. Our 
study indicated that the individuals who have SFA-
containing diet are more at risk of developing NAFLD. 
Further, in this study, the probability of risk of NAFLD 
was higher for those consuming fatty food, drinking 
sweet beverages, consuming red meat, and eating 
food faster. However, the probability was lower with 
consuming fruits and vegetables. 
Nevertheless, no relationship was observed 
between consuming breakfast and snack. Previous 
studies have been reported that skipping breakfast is 
associated with obesity, [34] and might be associated 
with the onset of NAFLD. On the other hand, the study 
by Imaizumi [28] did not report the relationship 
between skipping breakfast and NAFLD, which is in 
line with our study. Various studies have been 
reported a positive relationship between consuming 
carbohydrate as well as sweets and NAFLD [1], [30], 
[35]. 
When investigating dietary habits, it is 
important that the subjects are evaluated individually 
about overusing food and even proper eating 
behaviours. A number of nutritional patterns such as 
increasing food volume (eating out frequently, huge 
food volume per one meal, eating any kind of food), 
high energy diet (fast foods, outside food, and fried 
food), consuming suitable food and the manner of 
eating (being used to eating a load of food in the 
afternoon, eating in the evening, skipping breakfast, 
and eating fast) and over-consuming special nutrients 
have been shown to be associated with NAFLD [13]. 
Previous studies have considered a vegan diet and 
they have replaced red and fish meat with soybean 
and substituted refined carbohydrates with whole 
grains as effective for preventing fatty liver [36]. 
In the present study, although the subjects in 
the NAFLD group had shorter average sleep, no 
relationship was found between duration of sleep and 
NAFLD, which is consistent with the findings of the 
study by Trovato [22] and Katsagoni [29]. However, 
some studies have suggested that sleep duration has 
an inverse relationship with NAFLD, where short sleep 
duration is associated with increased risk of NAFLD 
[23], [29], [37], [38]. Sleep is an important factor for 
maintaining health, and short sleep duration is 
associated with obesity, diabetes, and fatty liver [39]. 
Generally, it is expected that improving lifestyle is 
important for preventing and treating NAFLD. 
Since the onset and progression of NAFLD 
are associated with lifestyle, thus nutritional 
therapeutic solutions, PA, and sleep and rest status 
are required for those with or at risk of NAFLD. 
Increasing physical activity and a healthy diet is a 
therapeutic target which may prevent progression of 
the metabolic status and weight gain in those with 
NAFLD, which should be taken into account in clinical 
care. 
Among the limitations of this study was using 
ultrasonography for diagnosing NAFLD. However, 
liver biopsy is the golden standard for fatty liver, but it 
is invasive and costly and is not recommended for the 
general population. Therefore, abdominal ultrasound 
was used in this study. The comments of two 
radiologists were used simultaneously to control this 
limitation. In comparison to histology, sonography is 
more reliable and accurate. Due to being inexpensive, 
safe, and available, it is the method of choice for 
screening fatty liver in clinical conditions and 
population settings [40]. 
On the other hand, the information related to 
diet, PA, and sleep of individuals was collected as 
self-reporting. In this method, under-reporting 
especially regarding diet in obese individuals might be 
a problem. To control it at least to some extent, 
attempts were made to provide sufficient explanation 
about the importance of correct reporting. Eventually, 
the cross-sectional nature of this study is a limitation 
which cannot determine causal relations, and the 
results should be confirmed in prospective studies. 
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